Ekonomi Haberleri

İçinde ('Altın ','USD ','Dolar ','EURO ','AVRO ','Faiz ','Gold ','Lira ','TRY ','USD ','Dollar ','cripto','crypto','Baş ','Chief ','Finance ','Finans ','Gayrimenkul','Kripto ','Küresel ') ve ('FED ','Stock ','NYSE ','S-400 ','F-35 ','Fitch ','S&P ','Moody's','Borsa ','IMKB ','Petrol ','Oil ','Merkez ','para ','money ','companies','company','Economist ','Ekonomist ','currencies','currency','Economy','Ekonomi','Economies','yatırım','Piyasa') ve ('ABD ',' US ',' EU ','Turkey','Turkish','Russia','China','Türkiye') kelime gruplarından en az 2 sinin içindeki kelimelerden birinin aynı anda geçtiği haberler.

Ekleyen: İnternet Robotu
Haber: Haber Kaynağı: Çeşitli Haber Siteleri
Mayo Clinic, Hibiscus BioVentures and Innoforce announce Mayflower cell and gene therapy accelerator
ROCHESTER, Minn., and ROCKVILLE, Md. — Mayo Clinic, Hibiscus BioVentures (Hibiscus) and Innoforce announce the launch of Mayflower BioVentures, a cell and gene therapy accelerator dedicated to identifying and forming companies around technologies that address unmet patient needs. This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies through preclinical and early feasibility studies. With a shared interest in identifying treatments and preventing disease,…
https://newsnetwork.mayoclinic.org/?p=347318
Etiketler:
Yorumları göster